ASF 1075

Drug Profile

ASF 1075

Alternative Names: ASF-1075

Latest Information Update: 29 Mar 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Astion Pharma A/S
  • Class Anti-inflammatories; Antipruritics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Dermatitis; Psoriasis

Most Recent Events

  • 29 Mar 2011 Discontinued - Phase-II for Dermatitis in Denmark (Topical)
  • 29 Mar 2011 Discontinued - Phase-II for Dermatitis in Germany (Topical)
  • 29 Mar 2011 Discontinued - Phase-II for Psoriasis in Germany (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top